TUBB2B
MOLECULAR TARGETtubulin beta 2B class IIb
TUBB2B (tubulin beta 2B class IIb) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TUBB2B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Colchicine | 4.93 | 138 |
| 2 | Nocodazole Nocodazole is | 3.37 | 28 |
| 3 | Podophyllotoxin | 2.94 | 18 |
| 4 | Vincristine | 2.56 | 12 |
| 5 | Noscapine | 1.10 | 2 |
| 6 | Demecolcine | 0.69 | 1 |
| 7 | Maytansine | 0.69 | 1 |
| 8 | vinblastine sulfate | 0.69 | 1 |
| 9 | Vorinostat | 0.69 | 1 |
About TUBB2B as a Drug Target
TUBB2B (tubulin beta 2B class IIb) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBB2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TUBB2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.